RESUMO
PURPOSE: To develop a deep-learning (DL)-based approach for thoracic lymph node (LN) mapping based on their anatomical location. METHOD: The training-and validation-dataset included 89 contrast-enhanced computed tomography (CT) scans of the chest. 4201â¯LNs were semi-automatically segmented and then assigned to LN levels according to their anatomical location. The LN level classification task was addressed by a multi-class segmentation procedure using a fully convolutional neural network. Mapping was performed by firstly determining potential level affiliation for each voxel and then performing majority voting over all voxels belonging to each LN. Mean classification accuracies on the validation data were calculated separately for each level and overall Top-1, Top-2 and Top-3 scores were determined, where a Top-X score describes how often the annotated class was within the top-X predictions. To demonstrate the clinical applicability of our model, we tested its N-staging capabilities in a simulated clinical use case scenario assuming a patient diseased with lung cancer. RESULTS: The artificial intelligence(AI)-based assignment revealed mean classification accuracies of 86.36 % (Top-1), 94.48 % (Top-2) and 96.10 % (Top-3). Best accuracies were achieved for LNs in the subcarinal level 7 (98.31 %) and axillary region (98.74 %). The highest misclassification rates were observed among LNs in adjacent levels. The proof-of-principle application in a simulated clinical use case scenario for automated tumor N-staging showed a mean classification accuracy of up to 96.14 % (Top-1). CONCLUSIONS: The proposed AI approach for automatic classification of LN levels in chest CT as well as the proof-of-principle-experiment for automatic N-staging, revealed promising results, warranting large-scale validation for clinical application.
